TRT Injection Frequency: How Often Should You Inject?

Most men on testosterone replacement therapy using standard injectable esters like testosterone cypionate or enanthate inject once a week or once every two weeks, with the Endocrine Society guideline listing both schedules as standard options. But “how often” is less a fixed rule and more a variable you adjust based on how your body handles each dose. The choice between weekly, biweekly, or even more frequent injections shapes how stable your testosterone levels stay, how you feel day to day, and which side effects you encounter.

What Clinical Guidelines Recommend

The 2018 Endocrine Society Clinical Practice Guideline, the most widely referenced standard for testosterone therapy in men, lists testosterone enanthate or cypionate at 150 to 200 mg intramuscularly every two weeks, or 75 to 100 mg per week, as the recommended dosing range. The guideline acknowledges a built-in problem with the every-two-week schedule: after a single intramuscular injection, testosterone levels climb into supraphysiological territory and then gradually fall into the hypogonadal range by the end of the dosing interval.¹ In plain terms, you start the two-week cycle with more testosterone than your body needs and end it with less than you started therapy to correct.

That guideline range is a starting point, not a final prescription. Your prescriber will typically check blood work four to six weeks after starting, then adjust the dose and timing based on your trough testosterone level (the reading taken just before your next injection) and how you feel. The goal is to keep trough levels in the mid-to-upper portion of the normal reference range without letting peaks climb too high.

Why the Interval Between Injections Matters So Much

Testosterone cypionate and enanthate are esterified forms of testosterone, meaning a chemical side chain has been attached that makes the hormone dissolve better in the oil carrier. This slows its release from the injection site into your bloodstream, extending its useful life from minutes (for plain testosterone) to roughly a week or so for these esters.² Even with that extended release, the level does not stay flat. It rises sharply within the first couple of days, then declines on a curve until the next shot.

When you stretch the interval to every two weeks, that curve becomes more dramatic. Early in the cycle you can end up with testosterone levels well above normal. Late in the cycle you can dip back into the range that caused your symptoms in the first place. Researchers studying TRT formulations have noted that long-acting preparations often produce supraphysiological levels initially, followed by subtherapeutic levels, failing to replicate the body’s natural daily rhythm.³ This roller coaster is what many men describe as “symptom cycling,” where energy, mood, and libido feel great for a few days after the injection and then gradually fade.

Every Two Weeks Versus Weekly

The every-two-week schedule persists largely because of convenience: fewer injections, fewer office visits if a clinician is administering them. But clinically, weekly injections of half the biweekly dose deliver the same total amount of testosterone with a much flatter curve. Peaks are lower because you are injecting less at a time, and troughs are higher because the next dose arrives before levels have dropped as far.

A detailed review on individualizing injectable TRT in primary care makes the case that every-two-week dosing should not be the automatic default for short-acting esters. Weekly dosing, it notes, is often a reasonable and effective schedule that many men tolerate well. The review also points out that some men on weekly injections still report symptom cycling, acne, oily skin, mood or sleep disturbance, breast tenderness, fluid retention, late-cycle fatigue, or changes in libido. When those complaints appear, the issue may be peak-to-trough variation rather than an inadequate total weekly dose.⁴ The fix in those cases is not more testosterone; it is more even delivery of the testosterone you are already taking.

Injecting More Often Than Once a Week

Twice-weekly, every-other-day, and even daily injection protocols are gaining ground in TRT practice. These schedules split the same weekly dose into smaller, more frequent shots, further leveling out the peaks and troughs. If you are on 100 mg per week, for instance, a twice-weekly protocol would have you inject 50 mg every three to four days.

The same primary-care review describes these more frequent regimens as optional tools rather than universal standards, useful when symptoms, hematocrit trends, estrogen-related side effects, blood pressure changes, fluid retention, low sex hormone-binding globulin, or patient preference suggest that a smoother exposure pattern would help.⁴ The logic is straightforward: smaller, more frequent doses keep the concentration of testosterone in your blood closer to a flat line, which can reduce the intensity of androgen-sensitive side effects like acne while also keeping estrogen conversion (which tracks with peak testosterone levels) more moderate.

A real-world study on fractionated dosing with testosterone gel (not injections, but illustrating the same pharmacologic principle) found that splitting the total dose into smaller daily portions lowered peak testosterone and raised the trough, resulting in a much narrower gap between the highest and lowest readings. The proportion of patients reaching target testosterone at peak jumped substantially, and no clinically meaningful changes appeared in hematocrit, hemoglobin, or prostate-specific antigen.⁵ The takeaway applies to injections in principle: dividing the dose into more frequent administrations smooths the curve.

Testosterone Undecanoate and the Long-Acting Option

Not every injectable testosterone follows a weekly or biweekly rhythm. Testosterone undecanoate (sold as Aveed in the United States or Nebido in many other countries) is a long-chain ester dissolved in castor oil, designed for much less frequent dosing. After an initial loading period, it is typically injected every 10 to 14 weeks.

A study examining the optimal interval for testosterone undecanoate in hypogonadal and transgender men found a median injection interval of 12 weeks, with an interquartile range of roughly 10 to 13 weeks. Age and body size influenced the ideal timing, but diagnosis and certain lab markers did not.⁶ The practical appeal is obvious: one injection every three months instead of every week. The trade-off is that undecanoate must be given by a healthcare provider (at least in the U.S., where home administration is not approved due to the risk of a rare oil microembolism reaction), so you lose the convenience of self-injection. It also means you are committed to a fixed dose interval with less room to fine-tune week to week.

Subcutaneous Versus Intramuscular Injections

The traditional route for testosterone cypionate or enanthate is intramuscular, typically into the thigh or gluteal muscles using a relatively long needle. Over the past decade, subcutaneous injection into the fat just below the skin (usually the abdomen or thigh) has become a widely used alternative. The needle is shorter and thinner, and most men find it considerably less uncomfortable.

Evidence, though still limited, suggests that subcutaneous testosterone in doses similar to intramuscular doses produces comparable blood levels and pharmacokinetics. Patients can safely self-administer subcutaneously with appropriate training, and the route is generally easier for people new to self-injection.⁷ From a frequency standpoint, this matters because the lower barrier to self-injection makes more frequent protocols (twice weekly, every other day) far more practical. Asking someone to perform a deep intramuscular injection every other day is a big ask. A quick subcutaneous poke with an insulin-type needle is much easier to sustain over months and years.

One thing the subcutaneous route does not eliminate is the risk of erythrocytosis, the most closely watched blood-related side effect of TRT. A cohort study of men receiving subcutaneous testosterone cypionate found that about a third developed new-onset erythrocytosis, with the rate similar between those injecting weekly and those injecting every two weeks.⁸ So while the subcutaneous route lowers the hassle of frequent injections, it does not let you skip hematocrit monitoring.

Skin Side Effects and Frequency

Acne, oily skin, and changes in hair growth or loss are among the most reported dermatological complaints during TRT. These are driven by androgenic stimulation of sebaceous glands and hair follicles, and they tend to flare in proportion to how high testosterone peaks climb after an injection. A scoping review on dermatological side effects of TRT noted that intramuscular preparations given at longer dosing intervals produce greater fluctuations in testosterone compared to transdermal or more frequently dosed options, and that these peaks and troughs can worsen acne, seborrhea, and hair-related changes.⁹

If you are dealing with persistent acne or greasy skin on TRT, the frequency of your injections is worth examining before adding another medication. Splitting the same weekly dose into two or more smaller injections often reduces the post-injection testosterone spike enough to calm down skin issues, without requiring any change to the total dose.

Erythrocytosis and the Hematocrit Question

Testosterone stimulates red blood cell production. That is a normal physiological effect, but when it pushes hematocrit (the percentage of your blood that is red blood cells) too high, blood becomes thicker and the risk of clotting events rises. Most clinicians set a hematocrit threshold around 52 to 54 percent as the point where action is needed, whether that means reducing the dose, increasing the injection frequency, or donating blood.

The relationship between frequency and hematocrit is not fully settled. On one hand, lower peaks from more frequent injections should, in theory, reduce the erythropoietic stimulus. On the other hand, the subcutaneous cohort study mentioned earlier found that roughly a third of men developed erythrocytosis regardless of whether they injected weekly or biweekly.⁸ Total weekly dose likely matters more than injection timing for this particular side effect. Either way, regular blood work is non-negotiable on TRT, regardless of how often you inject.

Prostate Safety and PSA During TRT

Concern about prostate cancer has historically been one of the biggest fears around testosterone therapy, rooted in decades-old observations that castrating men with prostate cancer slowed disease progression. The modern evidence tells a less alarming story, though monitoring remains important.

A study following hypogonadal men at high risk for prostate cancer (including men with prostatic intraepithelial neoplasia, a precancerous finding) through 12 months of TRT found that PSA rose only slightly and by a similar amount in both the high-risk group and the comparison group.¹⁰ Injection frequency per se is not the primary variable driving PSA levels. What matters more is the total testosterone exposure over time and ongoing PSA surveillance, which most guidelines recommend at baseline, three to six months after starting, and then annually.

Signs Your Current Schedule Might Need Adjusting

Blood work is the objective measure, but symptom patterns often provide the first clue that your injection frequency is off. A few signals worth paying attention to:

• End-of-cycle fatigue: If your energy, mood, or libido reliably dip in the last day or two before your next injection, your trough is probably too low. More frequent dosing or a slight dose increase can help.
• Post-injection irritability or anxiety: Feeling wired, aggressive, or anxious in the day or two after injecting can indicate that your peak is too high. Splitting the dose into more frequent, smaller injections lowers the spike.
• Acne that flares and fades cyclically: Breakouts that follow the injection calendar suggest androgen peaks are stimulating your sebaceous glands. Leveling out the curve often helps.
• Rising hematocrit: If your hematocrit creeps toward the upper limit, your prescriber may shorten the interval and reduce the per-injection dose, or simply lower the total weekly dose.
• Breast tenderness or nipple sensitivity: High peaks can lead to more conversion of testosterone to estradiol, which drives these symptoms. Flattening the curve often reduces estrogen-related complaints without needing an estrogen blocker.

Tracking symptoms in a simple log alongside your injection dates gives your provider far better data than a single snapshot blood draw. The combination of lab values and symptom timing is what drives smart adjustments to frequency.

Injection Site Rotation and Long-Term Tissue Health

When you are injecting frequently, what happens to the tissue at the injection site over months and years becomes a practical concern. Intramuscular injections can cause localized soreness, small amounts of scar tissue, and occasionally oil-filled lumps if the depot does not absorb fully. A case report documented severe fibrous myopathy with function-limiting muscle contractures in patients who received long-term repeated intramuscular injections in the same sites for chronic pain conditions.¹¹ Those cases involved different medications and very high injection volumes, but they illustrate the general principle that any injection site used too frequently and without rotation is at risk for cumulative tissue damage.

Rotating between at least three or four sites (alternating thighs, alternating sides of the abdomen for subcutaneous, or adding the deltoid for intramuscular) is the simplest way to reduce this risk. Subcutaneous injections deposit smaller volumes into fat rather than muscle, which generally produces less tissue trauma per injection and makes daily or every-other-day protocols more sustainable from a tissue-health standpoint.

How Body Composition and SHBG Affect the Right Frequency

Two men on the same dose and schedule can have very different experiences, and body composition is one reason why. Men with more body fat tend to convert more testosterone to estradiol through aromatase activity in fat tissue. This can lead to higher estrogen-related side effects at the same testosterone dose, and those side effects can be amplified by large peaks. More frequent injections lower the peak and, in some cases, reduce the amount of estrogen produced per cycle.

Sex hormone-binding globulin also plays a role. SHBG is a protein that binds testosterone in the blood, making it unavailable for use. Men with low SHBG have more free testosterone for any given total level, which means they may feel the peaks and troughs more intensely. The Cureus review on individualizing injectable TRT specifically flags low SHBG as a scenario where more frequent dosing can produce a smoother exposure pattern.⁴ If your SHBG is on the low side, you are effectively getting a larger “dose” of active testosterone right after injection, and that burst clears faster too. Splitting your injections helps smooth that out.

The testosterone undecanoate data reinforce a related point: body surface area significantly influenced the optimal injection interval for that long-acting ester.⁶ Larger men metabolized the depot faster and needed shorter intervals. The same principle, scaled differently, applies to short-acting esters. Your body is not an average; your schedule should not be one either.